Philips receives FDA Breakthrough Device Designation for laser-assisted IVC filter removal device
Limited options exist for embedded IVC filter removal, and independent studies indicate high success rates using a Philips excimer laser sheath
- Limited options exist for embedded IVC filter removal, and independent studies indicate high success rates using a Philips excimer laser sheath
Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the FDA has granted Breakthrough Device Designation (BDD) for a laser-assisted inferior vena cava (IVC) filter removal device. - The proposed device is intended for ablating tissue to remove an IVC filter when previous methods of removal have failed.
- Other identified long-term risks associated with IVC filters include lower limb deep vein thrombosis and IVC occlusion.
- The failure rate for IVC filter removal is high and limited options for removal exist if the filter has become difficult to remove.